Will I lose muscle on weight loss medication?

Quick read · 5 min

Last reviewed: April 2026Based on 3 clinical trialsEvery claim linked to source

Some lean mass loss happens with any weight loss. Body scans show that 75–79% of weight lost on newer medications is fat.

About 25–40% of weight lost on GLP-1 drugs is lean mass, not fat

This is similar to diet-only weight loss. Resistance training and adequate protein (1.2–1.6g per kg) can reduce lean mass loss significantly.

Semaglutide (Wegovy)

STEP 1 DEXA
79% fat
21% lean

For every 10 lbs lost, about 7.9 lbs was fat and 2.1 lbs was lean tissue

Tirzepatide (Zepbound)

SURMOUNT-1 DEXA
75% fat
25% lean

For every 10 lbs lost, about 7.5 lbs was fat and 2.5 lbs was lean tissue

Liraglutide (Saxenda)

SCALE DEXA
75% fat
25% lean

For every 10 lbs lost, about 7.5 lbs was fat and 2.5 lbs was lean tissue

Diet + exercise alone

Multiple studies
70% fat
30% lean

Typical range is 25–35% lean mass loss — medications are in the same range or better

Orforglipron (Foundayo): No DEXA body composition substudy has been published yet. Based on its GLP-1 mechanism, lean mass loss is expected to be in a similar range to other GLP-1 drugs.
Key insight
The medications do not make muscle loss worse than dieting alone. Rapid weight loss itself is the driver — regardless of how you lose it. The GLP-1 drugs actually show equal or better lean mass preservation compared to diet and exercise.

What this means in real pounds

For someone starting at 240 lbs, here is what the trial averages look like:

Semaglutide (Wegovy)
Total lost35.8 lbs
Fat lost28.3 lbs
Lean mass lost7.5 lbs
Tirzepatide (Zepbound)
Total lost50.2 lbs
Fat lost37.6 lbs
Lean mass lost12.5 lbs

Averages from clinical trials. Individual results depend on diet, exercise, starting weight, and genetics.

Drug-by-drug summary
Semaglutide has the best lean mass ratio (79% fat / 21% lean). Tirzepatide causes the most total fat loss but slightly more lean loss (75% fat / 25% lean). Liraglutide has the least absolute lean loss — but also the least total weight loss. For most people, resistance training matters 3× more than drug choice.

The two things that actually preserve muscle

Drug choice makes a modest difference (4 percentage points between semaglutide and tirzepatide). These two strategies have a much larger effect — shifting the ratio by 10–15 percentage points:

🏋️
Resistance training
2–3 sessions per week
This is the single most effective countermeasure. Lifting weights or bodyweight exercises signal your muscles to hold on to mass, even during a calorie deficit. Clinical evidence consistently shows this preserves significantly more lean mass than cardio or no exercise.
🥩
Protein intake
60–100g per day
Protein gives your muscles the building blocks they need to maintain themselves. Aim for 1.0–1.2g per kg of body weight daily. Eat protein first at every meal — this helps especially when your appetite is reduced on medication.
Key insight
Resistance training can shift the lean mass ratio by 10–15 percentage points. The difference between semaglutide and tirzepatide is only 4 points. In other words, what you do in the gym matters roughly 3× more than which drug you take.

Side effects for your specific medication

Muscle loss varies by drug. See the full side effect profile including DEXA body composition data:

Bottom line

  • Yes, some lean mass loss is unavoidable — but 75–79% of what you lose on medication is fat
  • Medications are not worse than dieting — diet alone causes 25–35% lean mass loss, the same or more
  • Resistance training is the biggest lever — 3× more impact on the ratio than drug choice
  • Muscle loss is not permanent — lean mass can be rebuilt with consistent strength training after weight stabilises

Next step most people take

Backed by evidence · Every claim linked to its source

Last reviewed: April 2026

Medical disclaimer: This website is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment.